Inventor
Fred Lawrence Ciske
Inventor
Dexter, MI, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes18%
A61LMethods or apparatus for sterilising materials or objects in general13%
C07CAcyclic or carbocyclic compounds2%
C07HSugars2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
11,066,361Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions202110,729,810Methods, systems, and compositions for promoting bone growth202010,556,862Difluorolactam compounds as EP20209,701,630'Difluorolactam compositions for EP4-mediated osteo related diseases and conditions'20179,688,627'Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions'20179,676,712'Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions'20179,487,478'Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions'20169,440,919'Difluorolactam compositions for EP4-mediated osteo related diseases and conditions'20169,180,116'Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions'20159,126,973'Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases'20159,120,820'Fluorescent molecular probes for use in assays that measure test compound competitive binding with SAM-utilizing proteins'20158,536,185'Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases'20138,450,326'Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases'20136,903,097'Heterocycle carboxamides as antiviral agents'20056,831,081'4-Oxo-4,7-dihydrothieno2,3-bpyridine-5-carboxamides as antiviral agents'20046,825,225'Bicyclic isoxazolinones as antibacterial agents'20046,624,159'Heterocycle carboxamides as antiviral agents'20036,559,145'Heterocycle carboxamides as antiviral agents'20036,365,612'Benzosultam oxazolidinone antibacterial agents'20026,004,959'Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999Based in Cincinnati, OH, US· patent location history
2002–2005Patents assigned to UPJOHN CO (5)· patent assignee history
2002–2005Based in Lawton, MI, US· patent location history
2013–2021Patents assigned to CAYMAN CHEMICAL CO INC (12)· patent assignee history
2013–2015Patents assigned to BARRETT STEPHEN DOUGLAS (2)· patent assignee history
2013–2015Patents assigned to CISKE FRED LAWRENCE (2)· patent assignee history
2013–2021Based in Dexter, MI, US· patent location history
2016–2020Patents assigned to MYOMETRICS LLC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CAYMAN CHEMICAL CO INC | 12 | 2013–2021 |
| MYOMETRICS LLC | 5 | 2016–2020 |
| UPJOHN CO | 5 | 2002–2005 |
| BARRETT STEPHEN DOUGLAS | 2 | 2013–2015 |
| CISKE FRED LAWRENCEself | 2 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Dexter, MI, US | 13 | 2013–2021 |
| Lawton, MI, US | 6 | 2002–2005 |
| Cincinnati, OH, US | 1 | 1999 |